Author: Michael Kalichman, 2001
Contributors: P.D. Magnus, Dena Plemmons
Updates: Michael Kalichman, 2016
What is a conflict of interest?
We often find ourselves faced with two or more competing interests, creating the perception, if not the reality, of an increased risk of bias or poor judgment.
We are most familiar with financial conflicts. For example, a researcher could be studying a new product for which they will receive significant financial rewards if their studies result in positive findings. However, conflicts can come from many other competing interests, such as career advancement or responsibilities to family or friends.
What should you do?
- Comply with regulations
Researchers should ask about and adhere to institutional and governmental requirements for identifying, disclosing, and managing conflicts of interest.
- Avoid and minimize conflict
Although it is not possible to avoid all sources of conflict, it is in the best interests of the scientific community and of individual scientists to recognize conflicts of interest and to take steps to nullify or mitigate those conflicts.
- Disclose interests
If conflicts cannot be avoided, then those conflicts should be disclosed. At minimum, the institution and any other parties with a significant interest should be made aware of the extent and nature of the conflict.
- Manage conflicts
Disclosure is often not enough. For every step of the research process, attempts should be made to isolate the conflicted individuals from all decision-making functions.
- Keep learning
Both the potential for conflicts of interest and the strategies for dealing with those conflicts are evolving. Considering the potential for misperceptions of a researcher's motives, it is best to assume that good intentions are not enough. Seek out information so as to comply with the spirit and letter of current regulations.
- We often find ourselves in situations where two or more competing interests create the perception -- or the reality -- of an increased risk of bias or poor judgment.
- Collectively, we refer to these challenging situations as conflicts of interest.
- Scientists have professional, fiduciary, and ethical interests in the responsible conduct of research, but these interests may be compromised by personal interests.
- Such conflicts are not inherently bad. Indeed, they are to be expected. It's how they are handled that can lead to improper, inappropriate, or bad outcomes.
Financial vs. Non-Financial Conflicts
A common worry is that financial interest in the outcomes of research can result in unethical behavior or even criminal misconduct.
However, it is also plausible that interests other than financial interests could compromise the responsible conduct of research.
Examples of non-financial interests that might conflict with the integrity of science include:
- career advancement
- publishable results
- service to patients or students
- family and friendships
Conflicts of Conscience
Another potential conflict can come in the form of conscience. An individual might suffer a conflict of conscience if, for example, the mission or expectations of the institution are incompatible with his or her personal values.
Risks of Conflicts of Interest
Risks of conflicts of interest are not merely hypothetical. Financial conflicts are associated with altered outcomes of research. For example:
Intentional Bias: Is it Research Misconduct?
Conflicts of interest do not necessarily amount to research misconduct. However, if the potential for personal gain is great, then principles that guide responsible conduct in research may be compromised. In an extreme case, it is conceivable that someone could knowingly compromise principles of good scientific practice in pursuit of a particular research finding our outcome.
Conflicting interests are more likely to result in unintentional rather than intentional bias. For example:
- Choices of topics, methods, and approaches may be made based on availability of financial support rather than the best science or the greatest needs.
- In the design of experiments, scientists may be unconsciously biased to choose, or stick with, approaches likely to provide marketable findings, rather than those designed to increase basic understanding of mechanisms.
- In the collection of data, a researcher with significant financial interests may unwittingly introduce bias into enrollment of subjects for a clinical trial, into evaluation of data dependent on subjective judgments, or even into the reading of objective measurements.
- Choices for data selection, statistical methods, and presentation of results could be affected by unintentional bias.
Disclosure of Conflicts
Declaring that you have a conflict of interest is typically called disclosure.
In practice disclosure of research conflicts usually occurs only for financial interests. Historically, such disclosure was not routine, even in the biomedical literature (Krimsky and Rothenberg, 2001):
Perceptions may outweigh even the best of practices
When large sums of money are involved, it may be difficult for the public, legislators, the judicial system, and even colleagues to be convinced that results were not biased for personal gain.
Perceived impropriety can result in consequences as damaging as if intentional misconduct had been committed.
With increased media, governmental, and public scrutiny, a researcher's reputation, research funding, and employment can depend as much on perceptions of integrity as on integrity itself.
A variety of regulations and guidelines govern the disclosure and management of conflict of interest. Although many concerns could be generalized to any form of conflict of interest, the focus of regulations tends to be financial. The most relevant of these are federal regulations, notably those of the Public Health Service (PHS) and National Science Foundation (NSF).
- "any remuneration received from the entity in the twelve months preceding the disclosure and the value of any equity interest in the entity as of the date of disclosure, when aggregated, exceeds $5,000."
- "Intellectual property rights and interests (e.g., patents, copyrights), upon receipt of income related to such rights and interests."
- "the occurrence of any reimbursed or sponsored travel (i.e., that which is paid on behalf of the Investigator and not reimbursed to the Investigator so that the exact monetary value may not be readily available), related to their institutional responsibilities."
Professional societies and journals are another important source for guidance on the management of conflicts of interest. These are quite variable in their scope and not always enforced, but three examples are noteworthy:
- Requirements for publication in the New England Journal of Medicine.
As early as 1984, the journal requested that "all authors disclose to [the Editor] any associations they had with businesses that could be affected by their work -- including direct employment and consultancy, stock ownership, and patent-licensing arrangements." (Angell and Kassirer, 1996).
- Policy statement from the American Society of Gene Therapy (ASGT).
The ASGT concluded that "investigators and team members directly responsible for patient selection, the informed consent process and/or clinical management in a trial must not have equity, stock options, or comparable arrangements in companies supporting the trial." (Woo, 2000).
- Guidelines from the Association of American Medical Colleges and the Association of American Universities (AAMC-AAU, 2008)
This report resulted in 15 recommendations to address conflicts of interest through the roles and responsibilities of individuals, institutions, and at the federal government.
- Define conflict of interest.
- List and describe three distinct conflicts of interest that are not financial.
- What interests, other than financial, do you have in obtaining positive results in your research?
- Why is a financial conflict of interest not necessarily considered to be misconduct? Discuss circumstances under which a financial conflict of interest might result in misconduct.
- If you were reading the work of another scientist, then what, if anything, do you need to know about interests of that scientist that might be in conflict with a published work? If it were relevant to the subject of the paper, which of the following would you want to know about an author's interests:
a. Financial stake (e.g., ownership, stock, stock options) in a company that markets the product discussed in the paper
b. Financial stake (e.g., ownership, stock, stock options) in a company that markets a product similar to the one discussed in the paper
c. Previous support (e.g., research materials, grants, or contracts) from a company that markets the product discussed in the paper
d. Current or previous role as a consultant with a company that markets the product discussed in the paper
e. Physical or psychological conditions (e.g., depression or diabetes) of the author that are also the subject of the paper
f. Sexual orientation of the author for research that excludes, or includes, a genetic basis for homosexuality
- AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research (2008): Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI Policies in Human Subjects Research. AAMC.
- Angell M, Kassirer JP (1996): Editorials and conflicts of interest. New England Journal of Medicine 335(14): 1055-6.
- Brainard J (2000): The Ties That Blind? (financing that might influence medical research) Chronicle of Higher Education. Sept. 8, 2000 47(2): A31.
- Krimsky S, Rothenberg LS (2001): Conflict of interest policies in science and medical journals: Editorial practics and author disclosures. Science and Engineering Ethics 7:205-218.
- NSF (2016): NSF Conflict of Interest Policy.
- PHS (2011): Subpart F—Promoting Objectivity in Research. Code of Federal Regulations.42 C.F.R. Part 50, Subpart F.
- Stelfox HT, Chua G, O'Rourke K, Detsky AS (1998): Conflict of interest in the debate over calcium-channel antagonists. New Engl J Med 338(2): 101-106.
- Woo SL (2000): Policy of the American Society of Gene Therapy on financial conflict of interest in clinical research. Mol Ther 1(5 Pt 1): 383-4.